172 related articles for article (PubMed ID: 28719625)
21. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.
Han ZJ; Xue WW; Tao L; Zhu F
CNS Neurosci Ther; 2018 Dec; 24(12):1253-1263. PubMed ID: 30106219
[TBL] [Abstract][Full Text] [Related]
23. Methylation factor MRPL15 identified as a potential biological target in Alzheimer's disease.
Gao L; Li J; Yan M; Aili M
Aging (Albany NY); 2021 May; 13(10):13560-13570. PubMed ID: 34016794
[TBL] [Abstract][Full Text] [Related]
24. A novel meta-analysis approach of cancer transcriptomes reveals prevailing transcriptional networks in cancer cells.
Niida A; Imoto S; Nagasaki M; Yamaguchi R; Miyano S
Genome Inform; 2010 Jan; 22():121-31. PubMed ID: 20238423
[TBL] [Abstract][Full Text] [Related]
25. Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.
Zang H; Li N; Pan Y; Hao J
Gynecol Endocrinol; 2017 Mar; 33(3):193-198. PubMed ID: 27809618
[TBL] [Abstract][Full Text] [Related]
26. An efficient algorithm to identify coordinately activated transcription factors.
Hu H
Genomics; 2010 Mar; 95(3):143-50. PubMed ID: 20060041
[TBL] [Abstract][Full Text] [Related]
27. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.
Zhang Y; Hayes A; Pritchard A; Thaker U; Haque MS; Lemmon H; Harris J; Cumming A; Lambert JC; Chartier-Harlin MC; St Clair D; Iwatsubo T; Mann DM; Lendon CL
Neurosci Lett; 2004 May; 362(2):99-102. PubMed ID: 15193763
[TBL] [Abstract][Full Text] [Related]
29. [Bioinformatics Analysis of Alzheimer's Disease].
Kikuchi M; Nakaya A
Brain Nerve; 2017 Jul; 69(7):835-842. PubMed ID: 28739998
[TBL] [Abstract][Full Text] [Related]
30. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ
Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180
[TBL] [Abstract][Full Text] [Related]
31. Age-related changes in gene expression are accelerated in Alzheimer's disease.
Saetre P; Jazin E; Emilsson L
Synapse; 2011 Sep; 65(9):971-4. PubMed ID: 21425351
[TBL] [Abstract][Full Text] [Related]
32. Integrated whole transcriptome and DNA methylation analysis identifies gene networks specific to late-onset Alzheimer's disease.
Humphries CE; Kohli MA; Nathanson L; Whitehead P; Beecham G; Martin E; Mash DC; Pericak-Vance MA; Gilbert J
J Alzheimers Dis; 2015; 44(3):977-87. PubMed ID: 25380588
[TBL] [Abstract][Full Text] [Related]
33. Immune blood biomarkers of Alzheimer disease patients.
Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M
J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling in Alzheimer's disease brain microvessels.
Wang S; Qaisar U; Yin X; Grammas P
J Alzheimers Dis; 2012; 31(1):193-205. PubMed ID: 22531426
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor regulatory network for early lung immune response to tuberculosis in mice.
Yaqubi M; Mohammadnia A; Fallahi H
Mol Med Rep; 2015 Aug; 12(2):2865-71. PubMed ID: 25955085
[TBL] [Abstract][Full Text] [Related]
36. Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
Conejero-Goldberg C; Hyde TM; Chen S; Herman MM; Kleinman JE; Davies P; Goldberg TE
J Alzheimers Dis; 2015; 48(4):969-78. PubMed ID: 26444771
[TBL] [Abstract][Full Text] [Related]
37. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation.
Crespo ÂC; Silva B; Marques L; Marcelino E; Maruta C; Costa S; Timóteo A; Vilares A; Couto FS; Faustino P; Correia AP; Verdelho A; Porto G; Guerreiro M; Herrero A; Costa C; de Mendonça A; Costa L; Martins M
Neurobiol Aging; 2014 Apr; 35(4):777-85. PubMed ID: 24199959
[TBL] [Abstract][Full Text] [Related]
38. Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease.
Song F; Qian Y; Peng X; Han G; Wang J; Bai Z; Crack PJ; Lei H
Curr Opin Pharmacol; 2016 Feb; 26():47-53. PubMed ID: 26480202
[TBL] [Abstract][Full Text] [Related]
39. Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.
Cacabelos R
Pharmacogenomics; 2004 Dec; 5(8):1049-105. PubMed ID: 15584876
[TBL] [Abstract][Full Text] [Related]
40. [Significant genes extraction and analysis of gene expression data based on matrix factorization techniques].
Kong W; Wang J; Mou X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):662-70. PubMed ID: 25219254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
